Mepron suspension is a liquid medication prescribed for the treatment of Pneumocystis jirovecii pneumonia (PCP), a serious lung infection that commonly affects individuals with weakened immune systems [1]. It contains the active ingredient atovaquone [2].
How does Mepron work?
Mepron works by interfering with the metabolic processes of Pneumocystis jirovecii. Specifically, it inhibits the synthesis of folate, an essential nutrient for the survival and replication of the fungus [3].
What is Mepron used for?
Mepron is primarily used for the treatment of mild to moderate PCP in patients who cannot tolerate trimethoprim-sulfamethoxazole, the usual first-line treatment [2][4]. It is also used for the prevention of PCP in individuals at high risk, such as those with HIV/AIDS and low CD4 counts, who cannot tolerate other prophylactic medications [4].
What are the potential side effects of Mepron?
Common side effects of Mepron suspension can include nausea, vomiting, diarrhea, headache, and rash [4]. Less common but more serious side effects may include liver problems, blood cell count changes, and allergic reactions [4]. Patients should report any persistent or severe side effects to their healthcare provider [4].
How is Mepron suspension administered?
Mepron suspension is typically taken orally with food, as this improves its absorption [3]. The dosage and frequency of administration depend on the specific condition being treated and the patient's individual response [2][4]. It is crucial to follow the prescribing physician's instructions carefully [4].
What are the alternatives to Mepron for PCP treatment?
The primary alternative treatment for PCP is trimethoprim-sulfamethoxazole (TMP-SMX) [4]. Other options may include pentamidine, dapsone, or combinations of medications, depending on the severity of the infection and the patient's tolerance to TMP-SMX [4].
What is the difference between Mepron and other PCP medications?
Mepron (atovaquone) and trimethoprim-sulfamethoxazole are both effective against Pneumocystis jirovecii, but they work through different mechanisms [3][4]. Atovaquone targets folate synthesis, while TMP-SMX inhibits different steps in the folate pathway [3]. Mepron is often chosen when a patient cannot tolerate TMP-SMX due to side effects or allergies [2][4].
Who makes Mepron?
Mepron is manufactured by Verxrx, formerly Valeant Pharmaceuticals International [5].